Skip to search.
 TSX Up 0.06% TSX Ventures Up 0.46%

Cytori Therapeutics, Inc. (CYTX)

-NasdaqCM
2.05 Up 0.02(0.99%) Aug 26, 4:00PM EDT
Prev Close:2.03
Open:2.01
Bid:1.47 x 1000
Ask:2.68 x 200
1y Target Est:7.33
Beta:3.00537
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:2.00 - 2.05
52wk Range:1.81 - 7.95
Volume:62,705
Avg Vol (3m):181,219
Market Cap:42.01M
P/E (ttm):N/A
EPS (ttm):-1.06
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CYTXUp 0.99%42.01M
BAXUp 0.17%25.66B
OSIRDown 1.19%171.92M
ASTM 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.59
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.48
Quarterly EPS Est (Sep-16) :-0.31
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cytori Therapeutics, Inc., a biotechnology company, develops cellular therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy consisting of a heterogeneous population of specialized cells, incl... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback